맞춤형 보충제 시장 예측(-2034년) : 성분 유형, 제형, 퍼스널라이제이션 방법, 용도, 최종사용자, 유통 채널 및 지역별 세계 분석

According to Stratistics MRC, the Global Personalized Supplements Market is accounted for $12.4 billion in 2026 and is expected to reach $37.4 billion by 2034 growing at a CAGR of 14.7% during the forecast period. Personalized supplements are customized nutritional formulations tailored to an individual's unique biochemical makeup, genetic profile, lifestyle factors, and specific health goals. Unlike traditional one-size-fits-all multivitamins, these bespoke products utilize data from DNA testing, blood biomarkers, gut microbiome analysis, and wearable technology to deliver precise nutrient combinations. The market represents a fundamental shift from reactive healthcare to proactive wellness management, empowering consumers to address deficiencies and optimize health through supplementation designed specifically for their biological needs and personal objectives.

Market Dynamics:

Driver:

Growing consumer demand for customized health solutions

Modern consumers are increasingly rejecting generic health products in favor of tailored approaches that acknowledge their unique biological and lifestyle circumstances. Direct-to-consumer genetic testing services have democratized access to personal biological data, creating awareness of individual nutritional needs and deficiencies that generic supplements cannot adequately address. The rise of wellness culture and preventive health strategies has shifted focus from treating illness to optimizing well-being, with personalized supplements positioned as sophisticated tools for this purpose. Social media influencers and health bloggers amplifying their positive experiences with customized regimens further normalizes personalized nutrition, driving mainstream adoption across demographic segments previously unfamiliar with supplementation.

Restraint:

High cost of personalized supplement programs

Premium pricing structures significantly limit market accessibility as comprehensive testing and custom formulation services remain expensive propositions for average consumers. Genetic analysis, biomarker assessments, and ongoing consultations with nutrition professionals add substantial costs beyond standard off-the-shelf supplement products. Manufacturing small-batch, customized formulations requires specialized production capabilities that lack the economies of scale enjoyed by mass-produced vitamin brands, further elevating price points. Insurance providers rarely cover these services as preventive wellness tools rather than medical necessities, placing the full financial burden on individual consumers. This cost barrier effectively segments the market toward affluent demographics, restricting broader population penetration.

Opportunity:

Integration with wearable health technology

Continuous data streams from fitness trackers, smartwatches, and connected health devices create unprecedented opportunities for dynamic supplement personalization. Wearables monitoring sleep patterns, activity levels, heart rate variability, and other physiological metrics provide real-time insights that can inform ongoing formulation adjustments far beyond static genetic testing. Companies developing algorithms that translate wearable data into actionable nutrient recommendations can offer subscription-based supplement services that evolve with changing consumer health status. This integration transforms personalized supplements from occasional purchases into continuous wellness partnerships, increasing customer lifetime value while delivering genuinely adaptive nutrition that responds to daily fluctuations in physical demands and recovery needs.

Threat:

Regulatory uncertainty and safety concerns

Inconsistent global regulatory frameworks for personalized nutrition products create significant compliance challenges and potential liability risks for market participants. Unlike standardized supplements with established safety profiles, customized formulations lack the extensive testing history that regulators rely upon for market approval decisions. Questions arise regarding quality control for small-batch manufacturing, ingredient sourcing verification, and appropriate labeling for patient-specific products. Regulatory authorities in major markets continue developing frameworks specific to personalized nutrition, creating uncertainty that discourages investment and expansion. Additionally, consumer safety incidents-even isolated-could trigger restrictive regulations that reshape the entire market landscape unfavorably.

Covid-19 Impact:

The COVID-19 pandemic dramatically accelerated personalized supplement adoption as consumers intensified focus on immune health and overall wellness resilience. Lockdown periods provided time for self-reflection and health prioritization, with many individuals completing at-home testing kits and exploring customized nutrition while working remotely. Supply chain disruptions affecting mass-market supplements highlighted the value of direct-to-consumer personalized services with dedicated production lines. The pandemic also normalized telehealth consultations and remote health monitoring, removing barriers to professional nutritional guidance. These behavioral changes proved durable, with post-pandemic consumers maintaining heightened engagement with personalized health solutions and expecting the convenience of at-home testing and online formulation services.

The Vitamins segment is expected to be the largest during the forecast period

The Vitamins segment is expected to account for the largest market share during the forecast period, reflecting their foundational role in human nutrition and widespread consumer familiarity. Vitamin deficiencies remain the most common nutritional gaps identified through genetic and biomarker testing, with Vitamin D, B12, and folate deficiencies frequently requiring correction through supplementation. Personalized vitamin formulations allow precise dosing adjustments based on individual absorption rates, genetic variants affecting metabolism, and lifestyle factors such as sun exposure and dietary restrictions. The extensive body of clinical research supporting vitamin supplementation provides credibility that newer ingredient categories lack, encouraging healthcare provider recommendations and consumer confidence in vitamin-focused personalized regimens throughout the forecast period.

The Gummies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Gummies segment is predicted to witness the highest growth rate, driven by consumer preferences for enjoyable, convenient dosage formats over traditional pills and capsules. Personalized gummy supplements appeal strongly to younger demographics who grew up with gummy vitamins and resist swallowing large tablets, while also attracting older consumers seeking more palatable options. Manufacturers have overcome previous challenges with heat-sensitive ingredient stability, enabling personalized gummy production that maintains nutrient efficacy while delivering appealing flavors and textures. The ability to create customized gummy shapes, colors, and flavor combinations further enhances the personalized experience, making daily supplementation feel like a treat rather than a chore, driving rapid adoption across multiple age segments.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high health awareness, advanced direct-to-consumer testing infrastructure, and favorable direct-to-consumer business regulations. The region hosts numerous pioneering personalized supplement brands that have established strong consumer relationships and refined manufacturing capabilities for custom formulations. Widespread adoption of genetic testing services, including ancestry and health screening, has familiarized consumers with personal biological data concepts applicable to nutritional personalization. Robust e-commerce logistics and subscription service acceptance facilitate direct-to-consumer business models dominating this market. Healthcare practitioner openness to complementary wellness approaches further validates personalized supplementation among North American consumers seeking evidence-based health optimization.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rising disposable incomes, increasing health consciousness, and traditional medicine integration opportunities. Rapidly expanding middle classes in China, India, and Southeast Asian countries demonstrate growing willingness to invest in preventive health and wellness products. Traditional medicine systems including Ayurveda and Traditional Chinese Medicine provide philosophical alignment with personalized approaches, creating receptive consumer bases. Government initiatives promoting digital health infrastructure and preventive care frameworks support testing and data collection essential for personalization. The region's large population base, combined with relatively low current market penetration, presents substantial growth potential as local players develop affordable personalized supplement solutions appropriate for regional preferences and price sensitivities.

Key players in the market

Some of the key players in Personalized Supplements Market include Nestle Health Science, Amway Corp., Herbalife Ltd., Glanbia plc, Abbott Laboratories, DSM-Firmenich AG, BASF SE, Persona Nutrition, Care/of, Rootine Inc., Nutrigenomix Inc., Viome Life Sciences, Inc., Baze Labs, Inc., Thorne HealthTech, Inc., Nature's Bounty Co., NOW Health Group, Inc., and Hum Nutrition Inc.

Key Developments:

In March 2026, Herbalife announced a definitive agreement to acquire assets from Bioniq, a UK-based personalized supplements company. The $150 million deal (including performance-based contingencies) integrates Bioniq's patented personalization engine into Herbalife's global distributor network, utilizing blood biomarkers and health data to scale tailored nutrition for consumers and elite athletes like Cristiano Ronaldo.

In March 2026, dsm-firmenich announced the expansion of its "Longevity Experience" for Vitafoods Europe, debuting new science-backed ingredients targeting cellular hallmarks of aging and personalized gut-brain health.

In October 2025, BASF launched Lutavit(R) A/D3 1000/200 NXT, a next-generation microencapsulated vitamin formulation designed for high stability and bioavailability in customized feed and supplement applications.

Ingredient Types Covered:

• Vitamins
• Minerals
• Amino Acids
• Herbal & Botanical Extracts
• Probiotics & Prebiotics
• Enzymes
• Omega Fatty Acids
• Other Ingredients

Dosage Forms Covered:

• Tablets
• Capsules
• Powders
• Liquids
• Softgels
• Gummies
• Other Forms

Personalization Approaches Covered:

• DNA-Based Personalization
• Blood-Based Personalization
• Microbiome-Based Personalization
• Lifestyle-Based Personalization
• Algorithm-Based Personalization

Applications Covered:

• General Wellness
• Immune Health
• Digestive Health
• Cognitive Health
• Sports Nutrition & Fitness
• Weight Management
• Skin, Hair & Beauty
• Chronic Health Management

End Users Covered:

• Adults
• Geriatric Population
• Athletes & Fitness Enthusiasts
• Pregnant Women
• Children & Adolescents

Distribution Channels Covered:

• Online
• Offline

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Personalized Supplements Market, By Ingredient Type

• 5.1 Vitamins
• 5.2 Minerals
• 5.3 Amino Acids
• 5.4 Herbal & Botanical Extracts
• 5.5 Probiotics & Prebiotics
• 5.6 Enzymes
• 5.7 Omega Fatty Acids
• 5.8 Other Ingredients

6 Global Personalized Supplements Market, By Dosage Form

• 6.1 Tablets
• 6.2 Capsules
• 6.3 Powders
• 6.4 Liquids
• 6.5 Softgels
• 6.6 Gummies
• 6.7 Other Forms

7 Global Personalized Supplements Market, By Personalization Approach

• 7.1 DNA-Based Personalization
• 7.2 Blood-Based Personalization
• 7.3 Microbiome-Based Personalization
• 7.4 Lifestyle-Based Personalization
• 7.5 Algorithm-Based Personalization

8 Global Personalized Supplements Market, By Application

• 8.1 General Wellness
• 8.2 Immune Health
• 8.3 Digestive Health
• 8.4 Cognitive Health
• 8.5 Sports Nutrition & Fitness
• 8.6 Weight Management
• 8.7 Skin, Hair & Beauty
• 8.8 Chronic Health Management

9 Global Personalized Supplements Market, By End User

• 9.1 Adults
• 9.2 Geriatric Population
• 9.3 Athletes & Fitness Enthusiasts
• 9.4 Pregnant Women
• 9.5 Children & Adolescents

10 Global Personalized Supplements Market, By Distribution Channel

• 10.1 Online
  • 10.1.1 Brand Websites
  • 10.1.2 E-commerce Platforms
• 10.2 Offline
  • 10.2.1 Pharmacies & Drug Stores
  • 10.2.2 Health & Wellness Stores
  • 10.2.3 Clinics & Nutrition Centers

11 Global Personalized Supplements Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 Nestle Health Science
• 14.2 Amway Corp.
• 14.3 Herbalife Ltd.
• 14.4 Glanbia plc
• 14.5 Abbott Laboratories
• 14.6 DSM-Firmenich AG
• 14.7 BASF SE
• 14.8 Persona Nutrition
• 14.9 Care/of
• 14.10 Rootine Inc.
• 14.11 Nutrigenomix Inc.
• 14.12 Viome Life Sciences, Inc.
• 14.13 Baze Labs, Inc.
• 14.14 Thorne HealthTech, Inc.
• 14.15 Nature's Bounty Co.
• 14.16 NOW Health Group, Inc.
• 14.17 Hum Nutrition Inc.